Stroke and Splenic Infarct in a 17-Year-Old Patient with COVID-Associated Hypercoagulable State and Relative ADAMTS13 Deficiency

Maximilian Pistor; Angelika Hoffmann; Thomas Horvath; Michael Oberholzer; Marcel Arnold; Sara Magdalena Pilgram-Pastor

doi:10.1177/2514183x211020157

You are currently viewing a new version of our website. To view the old version click .

Clinical and Translational Neuroscience is published by MDPI from Volume 5 Issue 2 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with SAGE.

Case Report

2 June 2021

Stroke and Splenic Infarct in a 17-Year-Old Patient with COVID-Associated Hypercoagulable State and Relative ADAMTS13 Deficiency

and

Department of Neurology, Inselspital University Hospital Bern, Freiburgstrasse 18, 3010 Bern, Switzerland

Department of Diagnostic and Interventional Neuroradiology, Inselspital University Hospital Bern, 3010 Bern, Switzerland

Author to whom correspondence should be addressed.

Clin. Transl. Neurosci.2021, 5(1), 7;https://doi.org/10.1177/2514183x211020157

Version Notes

Order Reprints

Abstract

In this case report, we present the case of a 17-year-old stroke patient suffering from coronavirus disease (COVID)-19. He was successfully treated with intravenous and endovascular treatment. After extensive work-up, a hypercoagulable state due to the COVID-19 infection was assumed as probable cause of stroke.

Keywords:

stroke; endovascular therapy; SARS-CoV2; ADAMTS13; hypercoagulable state; young stroke; COVID-19; COVID

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Myocardial Injury in Acute Ischemic Stroke

Joint European and World Stroke Organisation (ESO-WSO) Conference Highlights-2020